Your browser doesn't support javascript.
loading
Factor V Leiden mutation investigated by amplification created restriction enzyme site (ACRES) in PNH patients with and without thrombosis.
Nafa, K; Bessler, M; Mason, P; Vulliamy, T; Hillmen, P; Castro-Malaspina, H; Luzzatto, L.
Affiliation
  • Nafa K; Department of Human Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 0021, USA. k-nafa@ski.mskcc.org
Haematologica ; 81(6): 540-2, 1996.
Article in En | MEDLINE | ID: mdl-9009443
ABSTRACT
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired chronic hemolytic anemia characterized by intravascular hemolysis, often associated with neutropenia and thrombocytopenia. Venous thrombosis, including the Budd-Chiari syndrome, is one of the major complications of PNH, but not all PNH patients develop thrombosis. The basis for the high risk of thrombosis in PNH is not known. Recent reports have shown that Factor V Leiden mutation is a common cause of increased tendency to develop thrombosis. Fifty-six PNH patients were tested for Factor V Leiden mutation using Amplification Created Restriction Enzyme Site methods. PNH patients do not show an increased frequency of Factor V Leiden mutations.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Thrombophlebitis / Factor V / Hemoglobinuria, Paroxysmal / Mutation Limits: Humans Language: En Journal: Haematologica Year: 1996 Document type: Article Affiliation country: Estados Unidos
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Thrombophlebitis / Factor V / Hemoglobinuria, Paroxysmal / Mutation Limits: Humans Language: En Journal: Haematologica Year: 1996 Document type: Article Affiliation country: Estados Unidos
...